Pharma’s reputation ‘getting worse’
February 17, 2014Medical Communications, Sales and Marketing GSK, Gilead, Pfizer, ViiV, patientview, pharma, reputation
The pharma industry’s reputation is getting worse – at least, in the eyes of 800 patient groups – according to …
‘More than 2,000’ US lawsuits for Boehringer
February 14, 2014Sales and Marketing Boehringer, Pradaxa, Xarelto, blood thinner, warfarin
Boehringer Ingelheim is facing more than 2,000 lawsuits in the US over allegations that its stroke prevention pill Pradaxa has …
Former M&S chief executive to headhunt for NHS
February 14, 2014Medical Communications, Sales and Marketing Dalton, Hunt, NHS, stuart rose, superheads
Health secretary Jeremy Hunt has appointed the man accredited with turning around the fortunes of Marks and Spencer to advise …
Pfizer faces Australia action
February 14, 2014Medical Communications, Sales and Marketing Australia, Lipitor, Pfizer, accc
Pfizer has a legal battle on its hands in Australia, where the country’s consumer watchdog has begun proceedings in the …
Emperra appoints new chief executive
February 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing e-health, emperra, krey
Healthcare development firm Emperra E-Health Technologies has hired Dr Christian Krey as managing director and chief executive. Krey was previously …
Doctors highlight NHS data concerns
February 13, 2014Medical Communications, Sales and Marketing NHS, RGCP, UK, care data, doctors
Senior doctors have voiced their worries about the public’s lack of preparedness for the government’s planned roll-out of patient data …
FDA extends licence for Janssen’s Imbruvica
February 13, 2014Sales and Marketing FDA, Janssen, durect, imbruvica, leukaemia
Janssen and partner Pharmacyclics have been given an extended FDA approval for their new blood cancer treatment Imbruvica. The US …
Aesica hires director from Catalent
February 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aesica, Catalent, muir
Contract development and manufacturing organisation (CDMO) Aesica has appointed Ian Muir to the newly-created position of commercial managing director. Muir’s …
Kadcyla launches in UK
February 13, 2014Sales and Marketing CDF, Cancer, Kadcyla, NHS, Roche, breast
Roche’s Kadcyla, indicated to treat an aggressive form of breast cancer, has launched today in the UK.Kadcyla (trastuzumab emtansine) which …
NHS England savings ‘not used wisely’
February 12, 2014Sales and Marketing England, NHS, QIPP, Simon Stevens, health select
A group of influential MPs has raised serious concerns over what the £10 billion worth of NHS England savings made …
NICE: ‘Use more statins’
February 12, 2014Sales and Marketing NHS, NICE, baker, cvd, statins
NICE has decided more NHS patients ought to be considered at risk of cardiovascular disease (CVD) – and therefore advises …
ICR: ‘Pharma needs stronger incentives’
February 12, 2014Research and Development, Sales and Marketing ICR, cancer research, itcc, pharma, r and d
The pharma industry must be given greater monetary help to persuade it to develop drugs which are specifically for children, …
Teva under investigation for marketing practices
February 12, 2014Sales and Marketing Azilect, Copaxone, Teva, fines, generics
Teva Pharmaceuticals is under investigation by US authorities for sales and marketing activity around two of its drugs – including …
Merck KGaA pushes biosimilars
February 12, 2014Research and Development, Sales and Marketing Dr Reddy's, Merck KGaA, biosimilars, dr reddys, generics
Merck KGaA is to take big strides into the world of biosimilars, according to the German company’s chairman Karl-Ludwig Kley. …
New chief executive for Biotec
February 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotec, UK, withey
Pharma supplies firm Biotec Services International has promoted Dr Fiona Withey to the position of chief executive.



 Withey joined the …
RSA confirms three appointments
February 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing chin, foster, macdonald, rsa
Life sciences executive search and interim management firm RSA has increased the size of its offering with three new appointments. …
Concerns over big pharma links to NHS policy
February 12, 2014Research and Development, Sales and Marketing England, NHS, jmc, pharma, shca
NHS England has reportedly commissioned a big pharma lobby group to create an influential report, stoking fears that the five-year …
Merck in $100 million contraceptive settlement
February 10, 2014Sales and Marketing Merck, birth, birth control, legal, nuvaring
Merck has offered to pay $100 million to resolve thousands of legal claims brought against it for selling a birth …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
